175 related articles for article (PubMed ID: 28827223)
1. Long Noncoding RNA Facilitated Gene Therapy Reduces Atherosclerosis in a Murine Model of Familial Hypercholesterolemia.
Tontonoz P; Wu X; Jones M; Zhang Z; Salisbury D; Sallam T
Circulation; 2017 Aug; 136(8):776-778. PubMed ID: 28827223
[No Abstract] [Full Text] [Related]
2. Genetic Ablation of Transmembrane Prolyl 4-Hydroxylase Reduces Atherosclerotic Plaques in Mice.
Määttä J; Serpi R; Hörkkö S; Izzi V; Myllyharju J; Dimova EY; Koivunen P
Arterioscler Thromb Vasc Biol; 2021 Jul; 41(7):2128-2140. PubMed ID: 34039020
[TBL] [Abstract][Full Text] [Related]
3. microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator.
Jiang H; Zhang J; Du Y; Jia X; Yang F; Si S; Wang L; Hong B
Atherosclerosis; 2015 Dec; 243(2):523-32. PubMed ID: 26523989
[TBL] [Abstract][Full Text] [Related]
4. Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (
Burke AC; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Barrett PHR; Newton RS; Pickering JG; Huff MW
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1178-1190. PubMed ID: 29449335
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic silencing of FSP27 reduces the progression of atherosclerosis in Ldlr
Rajamoorthi A; Lee RG; Baldán Á
Atherosclerosis; 2018 Aug; 275():43-49. PubMed ID: 29859472
[TBL] [Abstract][Full Text] [Related]
6. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y
Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841
[TBL] [Abstract][Full Text] [Related]
7. Adoptive transfer of CX3CR1 transduced-T regulatory cells improves homing to the atherosclerotic plaques and dampens atherosclerosis progression.
Bonacina F; Martini E; Svecla M; Nour J; Cremonesi M; Beretta G; Moregola A; Pellegatta F; Zampoleri V; Catapano AL; Kallikourdis M; Norata GD
Cardiovasc Res; 2021 Jul; 117(9):2069-2082. PubMed ID: 32931583
[TBL] [Abstract][Full Text] [Related]
8. Sexually Dimorphic Relationships Among Saa3 (Serum Amyloid A3), Inflammation, and Cholesterol Metabolism Modulate Atherosclerosis in Mice.
Chait A; Wang S; Goodspeed L; Gomes D; Turk KE; Wietecha T; Tang J; Storey C; O'Brien KD; Rubinow KB; Tang C; Vaisar T; Gharib SA; Lusis AJ; Den Hartigh LJ
Arterioscler Thromb Vasc Biol; 2021 Jun; 41(6):e299-e313. PubMed ID: 33761762
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of experimental atherosclerosis by interleukin-19.
Ellison S; Gabunia K; Kelemen SE; England RN; Scalia R; Richards JM; Orr AW; Traylor JG; Rogers T; Cornwell W; Berglund LM; Goncalves I; Gomez MF; Autieri MV
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2316-24. PubMed ID: 23950143
[TBL] [Abstract][Full Text] [Related]
10. Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice.
Liu TT; Zeng Y; Tang K; Chen X; Zhang W; Xu XL
Atherosclerosis; 2017 Jul; 262():39-50. PubMed ID: 28500865
[TBL] [Abstract][Full Text] [Related]
11. Haloperidol inhibits the development of atherosclerotic lesions in LDL receptor knockout mice.
van der Sluis RJ; Nahon JE; Reuwer AQ; Van Eck M; Hoekstra M
Br J Pharmacol; 2015 May; 172(9):2397-405. PubMed ID: 25572138
[TBL] [Abstract][Full Text] [Related]
12. Sleeping Beauty Transposon Vectors in Liver-directed Gene Delivery of LDLR and VLDLR for Gene Therapy of Familial Hypercholesterolemia.
Turunen TA; Kurkipuro J; Heikura T; Vuorio T; Hytönen E; Izsvák Z; Ylä-Herttuala S
Mol Ther; 2016 Mar; 24(3):620-35. PubMed ID: 26670130
[TBL] [Abstract][Full Text] [Related]
13. TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1.
Zhang L; Cheng H; Yue Y; Li S; Zhang D; He R
Cardiovasc Pathol; 2018; 33():6-15. PubMed ID: 29268138
[TBL] [Abstract][Full Text] [Related]
14. Perinatal Hypercholesterolemia Exacerbates Atherosclerosis Lesions in Offspring by Altering Metabolism of Trimethylamine-N-Oxide and Bile Acids.
Trenteseaux C; Gaston AT; Aguesse A; Poupeau G; de Coppet P; Andriantsitohaina R; Laschet J; Amarger V; Krempf M; Nobecourt-Dupuy E; Ouguerram K
Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2053-2063. PubMed ID: 28935756
[TBL] [Abstract][Full Text] [Related]
15. Improving lipoprotein profiles by liver-directed gene transfer of low density lipoprotein receptor gene in hypercholesterolaemia mice.
Ou H; Zhang Q; Zeng J
J Genet; 2016 Jun; 95(2):311-6. PubMed ID: 27350674
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.
Meiler S; Baumer Y; Toulmin E; Seng K; Boisvert WA
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):323-31. PubMed ID: 25524771
[TBL] [Abstract][Full Text] [Related]
18. Exosome-based
Li Z; Zhao P; Zhang Y; Wang J; Wang C; Liu Y; Yang G; Yuan L
Theranostics; 2021; 11(6):2953-2965. PubMed ID: 33456582
[TBL] [Abstract][Full Text] [Related]
19. CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice.
Boulaftali Y; Owens AP; Beale A; Piatt R; Casari C; Lee RH; Conley PB; Paul DS; Mackman N; Bergmeier W
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):792-9. PubMed ID: 26988592
[TBL] [Abstract][Full Text] [Related]
20. ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.
Laguna-Fernandez A; Checa A; Carracedo M; Artiach G; Petri MH; Baumgartner R; Forteza MJ; Jiang X; Andonova T; Walker ME; Dalli J; Arnardottir H; Gisterå A; Thul S; Wheelock CE; Paulsson-Berne G; Ketelhuth DFJ; Hansson GK; Bäck M
Circulation; 2018 Oct; 138(16):1693-1705. PubMed ID: 29739755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
